Matthew D Wright1, Michele D Poe1, Anthony DeRenzo1, Shilpa Haldal1, Maria L Escolar2. 1. From the Program for the Study of Neurodevelopment in Rare Disorders, University of Pittsburgh, PA. 2. From the Program for the Study of Neurodevelopment in Rare Disorders, University of Pittsburgh, PA. maria.escolar@chp.edu.
Abstract
OBJECTIVE: To describe long-term outcomes of children with early-infantile Krabbe disease who underwent hematopoietic stem cell transplantation (HSCT) in the first 7 weeks of life. METHODS: In this prospective longitudinal study, evaluations performed at baseline and follow-up included brain imaging, neurodiagnostic tests, and neurobehavioral evaluations. RESULTS: Of the 18 patients in this study (11 girls, 7 boys; mean follow-up 9.5 years, range 4-15), 5 died (3 of peritransplant complications, 1 of a surgical complication unrelated to Krabbe disease, 1 of disease progression). One of the surviving patients has normal cognitive function and 10 continue to develop cognitive skills at a slightly slower rate than normal. All surviving patients continue to gain receptive language skills, with 7 falling within the normal range. Ten patients receive speech therapy, and 2 of these patients require augmentative communication devices. Gross motor development varies widely, but 3 patients can walk independently, and 7 walk with assistive devices. Spasticity ranges from mild to severe, and 12 patients wear orthotics. Fine motor skills are generally preserved. Brain myelination and atrophy stabilized in 8 patients, improved in 4 patients, and worsened in 1 patient. Nerve conduction velocities initially improved but continue to be abnormal in most patients. CONCLUSIONS: The surviving patients function at a much higher level than untreated children or symptomatic children who underwent HSCT. These results show that early HSCT changes the natural history of this disease by improving both lifespan and functional abilities. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for children with early-infantile Krabbe disease, early HSCT improves lifespan and functional abilities.
OBJECTIVE: To describe long-term outcomes of children with early-infantile Krabbe disease who underwent hematopoietic stem cell transplantation (HSCT) in the first 7 weeks of life. METHODS: In this prospective longitudinal study, evaluations performed at baseline and follow-up included brain imaging, neurodiagnostic tests, and neurobehavioral evaluations. RESULTS: Of the 18 patients in this study (11 girls, 7 boys; mean follow-up 9.5 years, range 4-15), 5 died (3 of peritransplant complications, 1 of a surgical complication unrelated to Krabbe disease, 1 of disease progression). One of the surviving patients has normal cognitive function and 10 continue to develop cognitive skills at a slightly slower rate than normal. All surviving patients continue to gain receptive language skills, with 7 falling within the normal range. Ten patients receive speech therapy, and 2 of these patients require augmentative communication devices. Gross motor development varies widely, but 3 patients can walk independently, and 7 walk with assistive devices. Spasticity ranges from mild to severe, and 12 patients wear orthotics. Fine motor skills are generally preserved. Brain myelination and atrophy stabilized in 8 patients, improved in 4 patients, and worsened in 1 patient. Nerve conduction velocities initially improved but continue to be abnormal in most patients. CONCLUSIONS: The surviving patients function at a much higher level than untreated children or symptomatic children who underwent HSCT. These results show that early HSCT changes the natural history of this disease by improving both lifespan and functional abilities. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for children with early-infantile Krabbe disease, early HSCT improves lifespan and functional abilities.
Authors: Maria L Escolar; Michele D Poe; James M Provenzale; Karen C Richards; June Allison; Susan Wood; David A Wenger; Daniel Pietryga; Donna Wall; Martin Champagne; Richard Morse; William Krivit; Joanne Kurtzberg Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: Z Y Lim; A Y L Ho; S Abrahams; A Fensom; M Aldouri; A Pagliuca; C Shaw; G J Mufti Journal: Bone Marrow Transplant Date: 2008-02-04 Impact factor: 5.483
Authors: W Krivit; E G Shapiro; C Peters; J E Wagner; G Cornu; J Kurtzberg; D A Wenger; E H Kolodny; M T Vanier; D J Loes; K Dusenbery; L A Lockman Journal: N Engl J Med Date: 1998-04-16 Impact factor: 91.245
Authors: M L Escolar; M D Poe; J K Smith; J H Gilmore; J Kurtzberg; W Lin; M Styner Journal: AJNR Am J Neuroradiol Date: 2009-04-22 Impact factor: 3.825
Authors: Joseph J Orsini; Denise M Kay; Carlos A Saavedra-Matiz; David A Wenger; Patricia K Duffner; Richard W Erbe; Chad Biski; Monica Martin; Lea M Krein; Matthew Nichols; Joanne Kurtzberg; Maria L Escolar; Darius J Adams; Georgianne L Arnold; Alejandro Iglesias; Patricia Galvin-Parton; David F Kronn; Jennifer M Kwon; Paul A Levy; Joan E Pellegrino; Natasha Shur; Melissa P Wasserstein; Michele Caggana Journal: Genet Med Date: 2016-01-21 Impact factor: 8.822
Authors: Michael S Marshall; Yazan Issa; Benas Jakubauskas; Monika Stoskute; Vince Elackattu; Jeffrey N Marshall; Wil Bogue; Duc Nguyen; Zane Hauck; Emily Rue; Subha Karumuthil-Melethil; Violeta Zaric; Maarten Bosland; Richard B van Breemen; Maria I Givogri; Steven J Gray; Stephen J Crocker; Ernesto R Bongarzone Journal: Mol Ther Date: 2018-01-17 Impact factor: 11.454
Authors: Allison M Bradbury; Jessica H Bagel; Duc Nguyen; Erik A Lykken; Jill Pesayco Salvador; Xuntian Jiang; Gary P Swain; Charles A Assenmacher; Ian J Hendricks; Keiko Miyadera; Rebecka S Hess; Arielle Ostrager; Patricia ODonnell; Mark S Sands; Daniel S Ory; G Diane Shelton; Ernesto R Bongarzone; Steven J Gray; Charles H Vite Journal: J Clin Invest Date: 2020-09-01 Impact factor: 14.808
Authors: Nadav I Weinstock; Daesung Shin; Narayan Dhimal; Xinying Hong; Eric E Irons; Nicholas J Silvestri; Chelsey B Reed; Duc Nguyen; Oliver Sampson; Yung-Chih Cheng; Joseph T Y Lau; Ernesto R Bongarzone; Julia Kofler; Maria L Escolar; Michael H Gelb; Lawrence Wrabetz; M Laura Feltri Journal: Neuron Date: 2020-05-05 Impact factor: 17.173
Authors: M Laura Feltri; Nadav I Weinstock; Jacob Favret; Narayan Dhimal; Lawrence Wrabetz; Daesung Shin Journal: Glia Date: 2021-04-14 Impact factor: 7.452
Authors: Yedda Li; Christopher A Miller; Lauren K Shea; Xuntian Jiang; Miguel A Guzman; Randy J Chandler; Sai M Ramakrishnan; Stephanie N Smith; Charles P Venditti; Carole A Vogler; Daniel S Ory; Timothy J Ley; Mark S Sands Journal: Mol Ther Date: 2021-01-01 Impact factor: 11.454